Pierre Amarenco Selected Research

Intracranial Embolism

6/2018	Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source.
10/2014	Feasibility and exploratory efficacy evaluation of the Embrella Embolic Deflector system for the prevention of cerebral emboli in patients undergoing transcatheter aortic valve replacement: the PROTAVI-C pilot study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pierre Amarenco Research Topics

Disease

140	Stroke (Strokes) 05/2024 - 01/2002
78	Ischemic Stroke 05/2024 - 01/2003
46	Transient Ischemic Attack 12/2023 - 09/2004
34	Hemorrhage 01/2024 - 07/2003
18	Atherosclerosis 12/2023 - 04/2003
18	Coronary Disease (Coronary Heart Disease) 01/2020 - 01/2003
16	Atrial Fibrillation 05/2024 - 11/2007
15	Brain Infarction 01/2024 - 01/2002
14	Embolic Stroke 08/2020 - 05/2009
13	Cardiovascular Diseases (Cardiovascular Disease) 11/2022 - 12/2005
13	Pathologic Constriction (Stenosis) 12/2020 - 04/2008
13	Myocardial Infarction 10/2019 - 01/2004
10	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2022 - 12/2004
9	Embolism (Embolus) 01/2021 - 09/2009
9	Carotid Artery Diseases 01/2020 - 12/2004
8	Infarction (Infarctions) 12/2021 - 04/2005
8	Hemorrhagic Stroke 01/2020 - 01/2004
6	Cerebral Infarction 01/2020 - 01/2014
6	Carotid Stenosis (Carotid Artery Stenosis) 01/2019 - 12/2008
6	Dyslipidemias (Dyslipidemia) 01/2019 - 02/2011
6	Vascular Diseases (Vascular Disease) 01/2018 - 07/2003
5	Cerebral Hemorrhage 05/2024 - 03/2013
5	Brain Ischemia (Cerebral Ischemia) 12/2023 - 10/2014
5	Type 2 Diabetes Mellitus (MODY) 11/2022 - 10/2011
5	Hypertension (High Blood Pressure) 01/2022 - 04/2003
5	Diabetes Mellitus 11/2019 - 09/2005
5	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2017 - 07/2003
4	Thrombosis (Thrombus) 01/2024 - 01/2009
4	Heart Failure 12/2018 - 06/2013
4	Lacunar Stroke 01/2014 - 04/2005
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2020 - 08/2007
3	Atherosclerotic Plaque (Atheroma) 09/2019 - 01/2003
3	Ischemia 10/2014 - 01/2007
3	Coronary Artery Disease (Coronary Atherosclerosis) 07/2014 - 12/2005
3	Arterial Occlusive Diseases (Arterial Occlusive Disease) 06/2014 - 09/2009
3	Neoplasms (Cancer) 09/2005 - 01/2002
2	Neurologic Manifestations (Neurological Manifestations) 05/2024 - 03/2012
2	Hypertriglyceridemia 11/2022 - 12/2018
2	Inflammation (Inflammations) 12/2020 - 10/2014
2	Frailty 01/2020 - 01/2019
2	Peripheral Arterial Disease 12/2018 - 06/2013

Drug/Important Bio-Agent (IBA)

43	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2023 - 07/2003
37	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023 - 01/2003
31	CholesterolIBA 11/2022 - 04/2003
27	LDL CholesterolIBA 01/2023 - 09/2005
24	LipidsIBA 01/2023 - 01/2003
21	oxidized low density lipoproteinIBA 01/2023 - 12/2004
20	TicagrelorIBA 01/2023 - 12/2015
19	Atorvastatin (Lipitor)FDA Link 01/2020 - 10/2006
16	RivaroxabanIBA 01/2021 - 01/2014
15	AnticoagulantsIBA 01/2022 - 09/2004
13	Triglycerides (Triacylglycerol)IBA 11/2022 - 04/2009
12	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2020 - 09/2004
11	HDL CholesterolIBA 11/2022 - 02/2008
11	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 10/2022 - 07/2003
9	Clopidogrel (Plavix)FDA Link 12/2023 - 09/2004
9	HDL LipoproteinsIBA 11/2022 - 06/2009
8	Biomarkers (Surrogate Marker)IBA 12/2020 - 01/2007
6	Lipoproteins (Lipoprotein)IBA 07/2020 - 06/2009
6	Vitamin K FDA Link 11/2019 - 01/2014
5	Ezetimibe (Zetia)FDA Link 01/2023 - 01/2020
5	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 12/2020 - 11/2008
5	Factor Xa (Coagulation Factor Xa)IBA 11/2019 - 01/2014
5	terutrobanIBA 03/2019 - 11/2011
4	Factor Xa InhibitorsIBA 05/2024 - 01/2014
4	Neuroprotective AgentsIBA 12/2020 - 07/2010
4	Warfarin (Coumadin)FDA LinkGeneric 01/2020 - 01/2014
4	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2017 - 12/2004
4	Fibric Acids (Fibrates)IBA 06/2011 - 01/2004
3	OsteopontinIBA 12/2020 - 09/2009
3	Matrix Metalloproteinases (MMPs)IBA 12/2020 - 04/2010
3	omega-Chloroacetophenone (Mace)IBA 01/2018 - 04/2016
3	bococizumabIBA 01/2017 - 08/2016
3	Trinitrotoluene (TNT)IBA 11/2016 - 04/2014
3	Glucose (Dextrose)FDA LinkGeneric 01/2015 - 04/2013
3	Blood Glucose (Blood Sugar)IBA 06/2014 - 06/2011
3	Niacin (Nicotinic Acid)FDA LinkGeneric 06/2011 - 06/2010
3	Antihypertensive Agents (Antihypertensives)IBA 05/2009 - 01/2003
2	Factor XIa (Coagulation Factor XIa)IBA 01/2024 - 10/2022
2	milvexianIBA 01/2024 - 10/2022
2	Factor XI (Plasma Thromboplastin Antecedent)IBA 01/2024 - 10/2022
2	(R)-2-(3-((benzoxazol-2-yl-d4 (3- (4- methoxyphenoxy- d7)propyl)amino)methyl)phenoxy) butanoic acidIBA 11/2022 - 12/2018
2	Retinaldehyde (Retinal)IBA 12/2021 - 01/2016
2	CytokinesIBA 04/2021 - 07/2006
2	ResistinIBA 12/2020 - 12/2017
2	AdiponectinIBA 12/2020 - 12/2017
2	CD40 Ligand (CD40L)IBA 12/2020 - 12/2017
2	ChemokinesIBA 12/2020 - 04/2005
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 12/2020 - 12/2017
2	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2020 - 04/2016
2	LDL Lipoproteins (beta Lipoproteins)IBA 01/2020 - 10/2006
2	PPAR alphaIBA 01/2019 - 12/2018
2	Insulin (Novolin)FDA Link 01/2019 - 01/2015

Therapy/Procedure

61	Therapeutics 05/2024 - 01/2003
17	Secondary Prevention 01/2022 - 01/2004
5	Thrombectomy 12/2023 - 09/2009
5	Thrombolytic Therapy 06/2015 - 09/2004
3	Carotid Endarterectomy 01/2017 - 03/2011
2	Contraindications 01/2020 - 01/2019
2	Aftercare (After-Treatment) 12/2018 - 05/2013